Open access
Aug 2026
Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda
These cases demonstrate that high-barrier drugs like DTG and Darunavir remain vulnerable when virological failure persists and adherence is suboptimal, and strengthening VL monitoring, access to genotypic testing and adherence support is essential to prevent Multiclass HIVDR.
Francis Kayinda, Lillian Betty Bakunzi, Edmund Okello et al.
· IDCases · 0 citations